Last reviewed · How we verify
Boric
At a glance
| Generic name | Boric |
|---|---|
| Sponsor | Indian Council of Medical Research |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Antiseptic preparation
Common side effects
Key clinical trials
- Vaginal Packing After Laparoscopic Sacrocolpopexy (NA)
- Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis (PHASE3)
- Sublingual Atropine Bioequivalence by Route of Administration (SABER) (PHASE1)
- Boric Acid Versus 10% Povidone Iodine Solution in Treatment of Otomycosis (NA)
- Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye (NA)
- A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution (PHASE3)
- A Single Group Study to Evaluate the Effects of a Boric Acid Suppository on Vaginal Health. (NA)
- Vulvovaginal Candidiasis in Canadian Females (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Boric CI brief — competitive landscape report
- Boric updates RSS · CI watch RSS
- Indian Council of Medical Research portfolio CI